Eargo 7 vs MDHearing Volt

The Eargo 7 is a premium-priced OTC hearing aid at $2,550, earning a B grade with a SoundScore of 3.4/5 in our lab testing. This invisible-in-ear device ranks #38 of 65 OTC hearing aids tested, placing it in the top 57% of its category. In our testing, the Eargo 7 demonstrates solid speech clarity in quiet environments, scoring 3.1/5—0.33 points above the OTC category average. Own-voice comfort also performs above average at 2.9/5, which is +0.39 points versus typical OTC devices, though only mixed in absolute terms. However, speech understanding in noisy situations is a weakness, scoring just 1.0/5, which falls 0.44 points below the category average. The most notable limitation is music streaming, which scored 0.0/5 in our lab measurements—1.92 points below the OTC average. Feedback handling is solid at 3.8/5 in absolute terms, though this is 0.74 points below the category average of 4.54/5. The Eargo 7 may appeal to users prioritizing a completely invisible design who primarily need help with speech in quieter settings. However, given its premium price point, consumers should note that several lower-priced alternatives in our database achieved higher overall sound scores. Those who frequently stream music or struggle in noisy environments may want to explore other options.

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.